Silo Pharma
SILO
15 hedge funds and large institutions have $412K invested in Silo Pharma in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 14 → 15 (+1)
2.53% less ownership
Funds ownership: 11.65% → 9.11% (-2.5%)
61% less capital invested
Capital invested by funds: $1.07M → $412K (-$657K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$164K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$116K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$28K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$26.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$657K |
| 2 |
VF
Virtu Financial
New York
|
-$44K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$11.4K |
| 4 |
SG
StoneX Group
New York
|
-$9.27K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.45K |
SILO Hedge Fund Activity: Q4 2025 in Review
15 of the 8,277 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2025, worth a combined $412K — down 61% from $1.07M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SILO positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $164K. The largest seller was Anson Funds Management, exiting entirely with an estimated $657K sold.
- 15 institutional investors held Silo Pharma (SILO) as of Q4 2025, up from 14 in Q3 2025.
- Funds reported $412K of Silo Pharma stock for Q4 2025, down 61% quarter-over-quarter.
- 4 funds opened new Silo Pharma positions in Q4 2025 and 3 closed out, a net change of +1 holder.
- The largest Silo Pharma buyer in Q4 2025 was DRW Securities, an estimated $164K added.
- The largest Silo Pharma seller in Q4 2025 was Anson Funds Management, an estimated $657K sold.
Based on aggregated 13F filings for Q4 2025.